sz324-8f36a4ab-9dc3-4663-a0e4-b059c8d42a73-v2.png

Outcome Data for Patients with Knee Injuries who received treatment with Regenexx®

Knee Patient Outcomes.

Knee Patient Outcomes.

Patient Outcome Data

Regenexx is unique in that it maintains an active patient registry that continually pings patients about their progress or side effects post procedure. As a result, we keep records on tens of thousands of Regenexx procedures performed by physicians in our network in our outcomes database. Nobody else on earth has tracked as many orthopedic stem cell patient results for as long as Regenexx.

In our effort to be completely transparent with potential patients, we make these results available through our website. You can see for yourself how many procedures we're tracking and what results patients have reported. With Regenexx, you have the tools you need to make an informed decision about what treatment option is right for you.

Please wait for the current data to load, then select the body part to view the latest patient outcome data. That data appears below the body part menu. 

Once a body part is selected, please scroll to the bottom of the page to view the number of patients contributing to the data along with three outcome reports specific to the body part.  

Knee conditions That may be affecting you!

Select links below to see patient outcome data

Patients with Osteoarthritis

Patients with ACL Injuries

Patients with Meniscus Injuries

Over 6403 knee Same Day* patients are being tracked in our Registry

Results for patients with Osteoarthritis with Lack of Joint function.

Patients value getting back to the activities they love, whether that is walking, running, skiing, or high-level sports. Prior to treatment, patients report that they are limited to 53% of their optimal function. After receiving treatment, they report averages up to 77%. The functional questionnaire represented here is the Lower Extremity Functional Scale (LEFS).    The number of patients reporting at these time-points are: 4374, 2359, 3387, 3228, 2713, 2020, 1619, 915, 473.    *Data updated March 04, 2019

Patients value getting back to the activities they love, whether that is walking, running, skiing, or high-level sports. Prior to treatment, patients report that they are limited to 53% of their optimal function. After receiving treatment, they report averages up to 77%. The functional questionnaire represented here is the Lower Extremity Functional Scale (LEFS).

The number of patients reporting at these time-points are: 4374, 2359, 3387, 3228, 2713, 2020, 1619, 915, 473.

*Data updated March 04, 2019


Results for patients with Osteoarthritis with Joint Pain

A main priority of Regenexx® is to decrease joint pain. Prior to receiving treatment, patients report average pain of nearly 5/10. After only 1-month, pain levels decrease to an average of 2.4/10, a decrease of 49%. Pain levels decrease further over time. The questionnaire used is the Numeric Pain Scale (NPS).    The number of patients reporting at these time-points are: 4971, 2387, 3417, 3260, 2734, 2034, 1621, 920, 476.    *Data updated March 04, 2019

A main priority of Regenexx® is to decrease joint pain. Prior to receiving treatment, patients report average pain of nearly 5/10. After only 1-month, pain levels decrease to an average of 2.4/10, a decrease of 49%. Pain levels decrease further over time. The questionnaire used is the Numeric Pain Scale (NPS).

The number of patients reporting at these time-points are: 4971, 2387, 3417, 3260, 2734, 2034, 1621, 920, 476.

*Data updated March 04, 2019


Overall Results for Knee Patients

Patients feel their joints are already 37% better after only 1-month, and continue to improve from there. The questionnaire used is the Single Assessment Numeric Evaluation (SANE).    The number of patients reporting at these time-points are: 2452, 3464, 3327, 2811, 2100, 1658, 930, 480.    *Data updated March 04, 2019

Patients feel their joints are already 37% better after only 1-month, and continue to improve from there. The questionnaire used is the Single Assessment Numeric Evaluation (SANE).

The number of patients reporting at these time-points are: 2452, 3464, 3327, 2811, 2100, 1658, 930, 480.

*Data updated March 04, 2019


Results for patients with ACL Tears with lack of Joint Funtion

Patients value getting back to the activities they love, whether that is walking, running, skiing, or high-level sports. Prior to treatment, patients report that they are limited to 58% of their optimal function. After receiving treatment, they report averages up to 88%. The functional questionnaire represented here is the Lower Extremity Functional Scale (LEFS).    The number of patients reporting at these time-points are: 221, 141, 173, 140, 87, 69, 59, 35, 26.    *Data updated March 04, 2019

Patients value getting back to the activities they love, whether that is walking, running, skiing, or high-level sports. Prior to treatment, patients report that they are limited to 58% of their optimal function. After receiving treatment, they report averages up to 88%. The functional questionnaire represented here is the Lower Extremity Functional Scale (LEFS).

The number of patients reporting at these time-points are: 221, 141, 173, 140, 87, 69, 59, 35, 26.

*Data updated March 04, 2019


Results for patients with ACL Tears and Joint Pain

A main priority of Regenexx® is to decrease joint pain. Prior to receiving treatment, patients report average pain of nearly 4/10. After only 1-month, pain levels decrease to an average of 1.9/10, a decrease of 49%. Pain levels decrease further over time. The questionnaire used is the Numeric Pain Scale (NPS).    The number of patients reporting at these time-points are: 230, 142, 174, 141, 87, 69, 59, 35, 26.    *Data updated March 04, 2019

A main priority of Regenexx® is to decrease joint pain. Prior to receiving treatment, patients report average pain of nearly 4/10. After only 1-month, pain levels decrease to an average of 1.9/10, a decrease of 49%. Pain levels decrease further over time. The questionnaire used is the Numeric Pain Scale (NPS).

The number of patients reporting at these time-points are: 230, 142, 174, 141, 87, 69, 59, 35, 26.

*Data updated March 04, 2019


Overall results for patients with ACL Tears

Patients feel their joints are already 33% better after only 1-month, and continue to improve from there. The questionnaire used is the Single Assessment Numeric Evaluation (SANE).    The number of patients reporting at these time-points are: 141, 173, 140, 88, 69, 59, 35, 27.    *Data updated March 04, 2019

Patients feel their joints are already 33% better after only 1-month, and continue to improve from there. The questionnaire used is the Single Assessment Numeric Evaluation (SANE).

The number of patients reporting at these time-points are: 141, 173, 140, 88, 69, 59, 35, 27.

*Data updated March 04, 2019


Results for patients with Meniscus Injuries with lack of Joint Funtion

Patients value getting back to the activities they love, whether that is walking, running, skiing, or high-level sports. Prior to treatment, patients report that they are limited to 51% of their optimal function. After receiving treatment, they report averages up to 76%. The functional questionnaire represented here is the Lower Extremity Functional Scale (LEFS).    The number of patients reporting at these time-points are: 413, 214, 327, 295, 239, 177, 134, 71, 45.    *Data updated March 04, 2019

Patients value getting back to the activities they love, whether that is walking, running, skiing, or high-level sports. Prior to treatment, patients report that they are limited to 51% of their optimal function. After receiving treatment, they report averages up to 76%. The functional questionnaire represented here is the Lower Extremity Functional Scale (LEFS).

The number of patients reporting at these time-points are: 413, 214, 327, 295, 239, 177, 134, 71, 45.

*Data updated March 04, 2019


Results for patients with Meniscus Injuries with Joint Pain

A main priority of Regenexx® is to decrease joint pain. Prior to receiving treatment, patients report average pain of nearly 5/10. After only 1-month, pain levels decrease to an average of 2.5/10, a decrease of 46%. Pain levels decrease further over time. The questionnaire used is the Numeric Pain Scale (NPS).    The number of patients reporting at these time-points are: 475, 216, 330, 295, 241, 181, 135, 72, 46.    *Data updated March 04, 2019

A main priority of Regenexx® is to decrease joint pain. Prior to receiving treatment, patients report average pain of nearly 5/10. After only 1-month, pain levels decrease to an average of 2.5/10, a decrease of 46%. Pain levels decrease further over time. The questionnaire used is the Numeric Pain Scale (NPS).

The number of patients reporting at these time-points are: 475, 216, 330, 295, 241, 181, 135, 72, 46.

*Data updated March 04, 2019


Overall results for patients with Meniscus Tears

Patients feel their joints are already 33% better after only 1-month, and continue to improve from there. The questionnaire used is the Single Assessment Numeric Evaluation (SANE).    The number of patients reporting at these time-points are: 214, 330, 298, 241, 181, 137, 72, 48.    *Data updated March 04, 2019

Patients feel their joints are already 33% better after only 1-month, and continue to improve from there. The questionnaire used is the Single Assessment Numeric Evaluation (SANE).

The number of patients reporting at these time-points are: 214, 330, 298, 241, 181, 137, 72, 48.

*Data updated March 04, 2019